Thanks to Advances in Genomics, PCR Is Becoming More Common in Clinical Applications Since its invention by Kary B. Mullis in 1985, the polymerase chain reaction (PCR) has become well established, ...

“We are thrilled to begin testing anywhere in the United States and worldwide with our first-of-their-kind mobile labs,” said Eric Canonico, CEO of MOTOPARA Foundation. “With the recent surge of COVID ...

LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...

CE-marked under the EU IVDR regulation, Diagnostics.AI's platform is the first to deliver AI algorithmic transparency and per-test auditability for clinical PCR diagnostics As the May 26th CE-IVDR ...

CHICAGO – The principal lab for a nationwide coronavirus testing company under investigation by several states is now the focus of a federal agency probing allegations of misconduct at the site. The ...

Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...

Dublin, Sept. 05, 2017 (GLOBE NEWSWIRE) -- The "PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)" report has been added to Research and Markets' offering. The report ...

Egan indicated all four indications—COVID-19, multiplex flu A/B, COVID-19 and RSV test, TB, and HPV—are expected to enter clinical trials during the remainder of 2025. "We anticipate to begin with the ...

Labroots is excited to announce the 14th Annual Event in the 2023 Clinical Diagnostics & Research Virtual Event Series taking place on November 8th, 2023! This event will again bring together ...

Labroots is excited to host the 16th Annual Clinical Diagnostics & Research Virtual Event Series on November 12, 2025. This premier online event unites clinicians, lab professionals, and researchers ...